Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2025-09-19 Interim / Quarterly Rep…
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Skonsolidowane sprawozdanie finansowe GK Scope Fluidics za H1 2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skrócone półroczne skonsolidowane sprawozdanie finansowe' (Condensed semi-annual consolidated financial report) for Scope Fluidics S.A. for the period ending June 30, 2025. It contains comprehensive financial statements (Statement of Profit or Loss, Statement of Financial Position, etc.) and detailed explanatory notes. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-19 Polish
Sprawozdanie z działalności GK Scope Fluidics za H1 2025
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the six-month period ending June 30, 2025, for Scope Fluidics S.A. It includes consolidated and standalone financial statements (balance sheets, income statements, cash flow statements), management discussion, and notes on accounting principles (IAS 34). It is clearly an interim/quarterly report rather than an annual report or a simple announcement. H1 2025
2025-09-19 Polish
Aktualizacja informacji dotyczących projektu HYBOLIC - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a short, formal announcement from the Management Board of Scope Fluidics S.A. regarding a change in the project timeline for the HYBOLIC project. It references a previous report (14/2025) and provides a specific update on operational milestones. Since it is a regulatory announcement regarding company operations that does not fit into specific categories like financial results, dividends, or board changes, it falls under the general regulatory filing category.
2025-09-16 Polish
Zgoda Rady Nadzorczej na podjęcie przez Scope Fluidics działań mających na celu zawarcie z Europejskim Bankiem Inwestycyjnym umów dotyczących pozyskanie finasowania dla projektu BACTEROMIC - Conten...
Capital/Financing Update Classification · 100% confidence The document is a regulatory announcement from Scope Fluidics S.A. regarding the progress of negotiations for a financing agreement (up to 15 million EUR) with the European Investment Bank (EIB) for the BACTEROMIC project. It details the terms of the potential financing, including tranches, interest rates, warrant issuance, and conditions for drawdown. Since this document details specific financing activities, capital structure changes, and debt-related funding arrangements, it falls under the 'Capital/Financing Update' category.
2025-09-15 Polish
Zmiana terminu publikacji raportu za I półrocze 2025 r. - Content (PL)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (397 characters) from Scope Fluidics S.A. regarding a change in the scheduled publication date for their consolidated report for the first half of 2025. It does not contain the report itself, but rather notifies stakeholders of a change in the reporting calendar. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-09-09 Polish
Osiągnięcie pierwszego celu oraz zatwierdzenie do realizacji drugiego celu w projekcie EDOCERA - Content (PL)
Regulatory Filings Classification · 96% confidence The document is a 'raport bieżący' (current report) issued by Scope Fluidics S.A. regarding the progress of a specific project (EDOCERA). It details project milestones, budget estimates, and R&D status. Since it is a regulatory announcement regarding company operations and project status that does not fit into specific categories like financial results, dividends, or board changes, it falls under the general regulatory filing category.
2025-08-06 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.